← stocks-llm Find companies like SMTI →

SANARA MEDTECH INC (SMTI)

Health Care · Surgical wound care and bone fusion implants · NASDAQ

Sanara MedTech develops surgical wound care and bone fusion implant solutions designed to improve clinical outcomes and reduce healthcare costs in the operating room.

What SANARA MEDTECH INC does

Sanara MedTech is a medical technology company developing and commercializing surgical solutions focused on soft tissue repair and bone fusion products. The company's primary offerings include CellerateRX Surgical Powder (a hydrolyzed collagen for surgical wound management), BIASURGE Advanced Surgical Solution (a sterile surgical irrigation solution), BiFORM Bioactive Moldable Matrix (an osteoconductive implant for bone fusion), and ALLOCYTE Plus Advanced Viable Bone Matrix. These products are designed to improve clinical outcomes and reduce healthcare expenditures in surgical settings.

Themes: ["Surgical wound care","Bone fusion implants","Soft tissue repair","Orthopedic and surgical solutions"]

Fundamentals

Ask why SMTI looks like this →

Key risks (from latest filing)

["Revenue declining with -10.8% YoY growth and negative net margins of -38.64%, indicating ongoing profitability challenges","Significant debt burden of $46.2 million in long-term debt against a relatively small equity base of $7.0 million, creating substantial financial leverage risk","Dependence on market acceptance and clinical adoption of proprietary surgical products in a competitive surgical solutions market"]

See SMTI's biggest risks from its latest 10-Q →

Competitors & peers

Not quite? Describe exactly what you want →

Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.

Last updated 2026-07-09.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.